161 related articles for article (PubMed ID: 34427336)
21. Evaluation of cell death after treatment with extracorporeal photopheresis.
Daniele N; Del Proposto G; Cerrone P; Sinopoli S; Sansone L; Gadaleta DI; Lanti A; Ferraro AS; Spurio S; Scerpa MC; Zinno F; Adorno G; Isacchi G
Transfus Apher Sci; 2012 Feb; 46(1):53-7. PubMed ID: 22138605
[TBL] [Abstract][Full Text] [Related]
22. Effect of UVA and 8-methoxypsoralen, 4, 6, 4'-trimethylangelicin or chlorpromazine on apoptosis of lymphocytes and their recognition by monocytes.
Wolnicka-Glubisz A; Fraczek J; Skrzeczynska-Moncznik J; Friedlein G; Mikolajczyk T; Sarna T; Pryjma J
J Physiol Pharmacol; 2010 Feb; 61(1):107-14. PubMed ID: 20228422
[TBL] [Abstract][Full Text] [Related]
23. Extracorporeal photochemotherapy.
Maeda A
J Dermatol Sci; 2009 Jun; 54(3):150-6. PubMed ID: 19369039
[TBL] [Abstract][Full Text] [Related]
24. [The modified extracorporeal photochemotherapy promotes apoptosis of spleen lymphocytes].
Zhou L; Du G; Zheng D; Liu Z; Wei Y; Chen W; Zhu Z; Song J; Fu X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1099-102. PubMed ID: 25270216
[TBL] [Abstract][Full Text] [Related]
25. Apoptosis in leukocytes induced by UVA in the presence of 8-methoxypsoralen, chlorpromazine or 4,6,4'-trimethylangelicin.
Wolnicka-Głubisz A; Rijnkels JM; Sarna T; Beijersbergen van Henegouwen GM
J Photochem Photobiol B; 2002 Nov; 68(2-3):65-72. PubMed ID: 12468199
[TBL] [Abstract][Full Text] [Related]
26.
Budde H; Berntsch U; Riggert J; Legler TJ
Cent Eur J Immunol; 2017; 42(1):1-9. PubMed ID: 28680325
[TBL] [Abstract][Full Text] [Related]
27. The concurrent administration of imatinib with extracorporeal photopheresis leads to complete and durable responses in patients with refractory sclerotic type chronic graft-versus-host disease.
Alsuliman T; Magro L; Coiteux V; Gauthier J; Srour M; Lionet A; Beauvais D; Yakoub-Agha I
Curr Res Transl Med; 2020 Apr; 68(2):71-76. PubMed ID: 31631014
[TBL] [Abstract][Full Text] [Related]
28. Monitoring of 8-methoxypsoralen during extracorporeal photochemotherapy: evidence for a "first-dose" effect.
Jacolot A; Tod M; Heudes AM; Petitjean O; Laroche L
Ther Drug Monit; 1996 Jun; 18(3):234-9. PubMed ID: 8738761
[TBL] [Abstract][Full Text] [Related]
29. In vitro treatment of monocytes with 8-methoxypsolaren and ultraviolet A light induces dendritic cells with a tolerogenic phenotype.
Legitimo A; Consolini R; Failli A; Fabiano S; Bencivelli W; Scatena F; Mosca F
Clin Exp Immunol; 2007 Jun; 148(3):564-72. PubMed ID: 17386076
[TBL] [Abstract][Full Text] [Related]
30. Photopheresis with UV-A light and 8-methoxypsoralen leads to cell death and to release of blebs with anti-inflammatory phenotype in activated and non-activated lymphocytes.
Stadler K; Frey B; Munoz LE; Finzel S; Rech J; Fietkau R; Herrmann M; Hueber A; Gaipl US
Biochem Biophys Res Commun; 2009 Aug; 386(1):71-6. PubMed ID: 19501044
[TBL] [Abstract][Full Text] [Related]
31. Photopheresis; the risk of photoallergy.
van Iperen HP; Beijersbergen van Henegouwen GM
J Photochem Photobiol B; 1996 Jul; 34(2-3):225-8. PubMed ID: 8810540
[TBL] [Abstract][Full Text] [Related]
32. Extracorporeal photopheresis in cutaneous T-cell lymphoma and graft-versus-host disease induces both immediate and progressive apoptotic processes.
Bladon J; Taylor PC
Br J Dermatol; 2002 Jan; 146(1):59-68. PubMed ID: 11841367
[TBL] [Abstract][Full Text] [Related]
33. Photodegradation of folic acid during extracorporeal photopheresis.
Der-Petrossian M; Födinger M; Knobler R; Hönigsmann H; Trautinger F
Br J Dermatol; 2007 Jan; 156(1):117-21. PubMed ID: 17199577
[TBL] [Abstract][Full Text] [Related]
34. Biological quality control for extracorporeal photochemotherapy: Assessing mononuclear cell apoptosis levels in ECP bags of chronic GvHD patients.
Taverna F; Coluccia P; Arienti F; Birolini A; Terranova L; Mazzocchi A; Rini F; Mariani L; Melani C; Ravagnani F
J Clin Apher; 2015 Jun; 30(3):162-70. PubMed ID: 25220858
[TBL] [Abstract][Full Text] [Related]
35. The effect of UVA light/8-methoxypsoralen exposure used in Extracorporeal Photopheresis treatment on platelets and extracellular vesicles.
Macleod H; Weiss L; Kelliher S; Kevane B; Ní Áinle F; Maguire PB
PLoS One; 2024; 19(2):e0293687. PubMed ID: 38416722
[TBL] [Abstract][Full Text] [Related]
36. Technical comparison of four different extracorporeal photopheresis systems.
Brosig A; Hähnel V; Orsó E; Wolff D; Holler E; Ahrens N
Transfusion; 2016 Oct; 56(10):2510-2519. PubMed ID: 27456672
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of lymphocytes inactivation by extracorporeal photopheresis using tetrazolium salt based-assay.
Chieregato K; Alghisi A; Borghero C; Elice F; Raimondi R; Zanetti E; Rodeghiero F; Astori G
Transfus Apher Sci; 2015 Oct; 53(2):242-5. PubMed ID: 26051797
[TBL] [Abstract][Full Text] [Related]
38. Chlorpromazine, a candidate drug for photopheresis.
van Iperen HP; Beijersbergen van Henegouwen MJ
J Photochem Photobiol B; 1996 Jul; 34(2-3):217-24. PubMed ID: 8810539
[TBL] [Abstract][Full Text] [Related]
39. American council on ECP (ACE): Why now?
Edelson R; Wu Y; Schneiderman J
J Clin Apher; 2018 Aug; 33(4):464-468. PubMed ID: 29575114
[TBL] [Abstract][Full Text] [Related]
40. In vitro PUVA treatment triggers calreticulin exposition and HMGB1 release by dying T lymphocytes in GVHD: New insights in extracorporeal photopheresis.
Coppard C; Hannani D; Humbert M; Gauthier V; Plumas J; Merlin E; Gabert F; Chaperot L
J Clin Apher; 2019 Aug; 34(4):450-460. PubMed ID: 30860623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
